AMGEN INC — Director's Dealing 2020

Aug 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2020-08-18

Reporting Person: AMGEN INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-18	American Depositary Shares	A	40000	$230.1797	Acquired	18213065	Direct
2020-08-19	American Depositary Shares	A	64176	$234.8768	Acquired	18277241	Direct
2020-08-20	American Depositary Shares	A	64176	$234.9941	Acquired	18341417	Direct

Footnotes

F1: This transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.

F2: The price reported is an average price. These American Depositary Shares ("ADSs") were purchased at prices ranging from $223.35 to $235.21 per ADS. Full information regarding the number of ADSs purchased at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F3: The price reported is an average price. These ADSs were purchased at prices ranging from $231.33 to $237.16 per ADS. Full information regarding the number of ADSs purchased at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F4: The price reported is an average price. These ADSs were purchased at prices ranging from $229.60 to $237.93 per ADS. Full information regarding the number of ADSs purchased at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F5: As each ADS represents 13 Ordinary Shares of the Issuer, the reported securities represent 238,438,421 Ordinary Shares.